GovChime
Notice ID: f66b0def19bc4d39b935220b1722cdd3Special Notice

FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

Active, responses due . Full description on SAM.gov.

Overview

Response deadline
5:00 PM EST
Posted
November 17, 2026
Notice type
Special Notice
Set-aside
No Set aside used
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION

Notice details

Office
FDA OFFICE OF ACQ GRANT SVCS
Last updated
Nov 17, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
FDABAA-27-00123
Notice ID
f66b0def19bc4d39b935220b1722cdd3

Description

Amendment 001 - 10/30/26 - Updated the proposal due date from 2/1/27 at 5:00 pm to 1/22/27 at 5:00 pm.
Updated the Special Notice Archive date from 15 days after response date to 09/30/27.

Amendment 002 - 11/16/26:

Summary of changes BAA Notice (FDABAA-27-00123)  - Amendment 002:

  • Page 2 – Added updated information on BAA Day.
    • BAA Day: FY27 FDA BAA Day will provide an opportunity to learn more about the application process and the FDA’s priorities for regulatory science research. Fiscal Year (FY) 2027 FDA Broad Agency Announcement Day - 12/08/2026 | FDA
  • Page 7 – Added updated information on BAA Day.
    • BAA Day for FY2027 will be hosted on December 8, 2026 from 1:00 PM - 4:00 PM Eastern Standard Time, as a virtual only event and will provide an opportunity to learn more about the application process and FDA’s priorities for regulatory research (Fiscal Year (FY) 2027 FDA Broad Agency Announcement Day - 12/08/2026 | FDA).
  • Page 14 – Added new research interest to Section - 2. Enhancing Nonclinical Development
    • 16. Compare multiple human tooth enamel evaluation techniques (including but not limited to surface and cross-sectional microhardness) to explore critical parameters and refine demineralization-remineralization NAMs for the testing of over-the-counter anticaries dentifrice drug products.
  • Page 52 – Updated Section - 22 - Tobacco and Nicotine with Super Intelligence (SI)
    • (SI)[18]
    • [18] Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI)
  • Page 53-56 - Section - 22 - Tobacco and Nicotine
    • Updated numerical bullet points. The content did not change.
  • Added page numbers to the footer of the BAA Notice.

Notice:

In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. 

FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. 

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (6)

  • BAA Notice Conformed through Amendment 002 CLEAN 11.16.26.pdf

    804 KBAdded in Special Notice version 4Posted
    Download
  • FY27 BAA - Amendment 002 - Summary of Changes.pdf

    207 KBAdded in Special Notice version 4Posted
    Download
  • BAA Notice Final 10.29.26.docx

    316 KBAdded in Special Notice version 1Posted
    Download
  • Attachment_6_SOW_Template.docx

    16 KBAdded in Special Notice version 1Posted
    Download
  • Cost_Appendix_7_Proposal_Template.xlsx

    196 KBAdded in Special Notice version 1Posted
    Download
  • Cost_Appendix_8_PreawardSurvey_Accounting_System.pdf

    1.4 MBAdded in Special Notice version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Special Notice

    FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

    Notice e5782fbc4927487eb38281ad47186a13 on SAM.gov

  2. 2
    Version 2Special Notice

    FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

    Notice 85dacc8ad6aa4cd59ae08f37a9f63355 on SAM.gov

  3. 3
    Version 3Special Notice

    FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

    Notice e390f6eca368408c9688dd06869b216a on SAM.gov

  4. 4
    Version 4Special NoticeCurrent

    FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

    Notice f66b0def19bc4d39b935220b1722cdd3 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

FDABAA-27-00123

Archive Date

Sep 30, 2027

Office Address

Rockville, MD, 20852